PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens–associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease

Kuan-Yin Tseng, Tung-Tai Kuo, Pi-Kai Chang, Jian-Liang Chou, Eagle Yi-Kung Huang, Nigel H Greig, Ho-Il Choi, Lars Olson, Barry J Hoffer, Yuan-Hao Chen · 2026

Read PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens–associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease by Kuan-Yin Tseng, Tung-Tai Kuo, Pi-Kai Chang, Jian-Liang Chou, Eagle Yi-Kung Huang, Nigel H Greig, Ho-Il Choi, Lars Olson, Barry J Hoffer, Yuan-Hao Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473357.txt.

Description

BackgroundNeuropsychiatric symptoms such as anxiety and depression substantially impair quality of life in Parkinson's disease (PD), yet the underlying neural circuits remain poorly defined. The MitoPark (MP) mouse, a dopaminergic mitochondrial dysfunction model, recapitulates both motor and non-motor features of PD.

Catalog record

CREATORKuan-Yin Tseng, Tung-Tai Kuo, Pi-Kai Chang, Jian-Liang Chou, Eagle Yi-Kung Huang, Nigel H Greig, Ho-Il Choi, Lars Olson, Barry J Hoffer, Yuan-Hao Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473357

Browse the full library · About the Tower of Babel